All data are based on the daily closing price as of May 12, 2026
s

Sam Chun Dang Pharm

000250.KQ
278.36 USD
0.00
0.00%

Overview

Last close
278.36 usd
Market cap
5.96B usd
52 week high
666.72 usd
52 week low
61.87 usd
Target price
41.59 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
40.5776
Price/Book Value
34.0417
Enterprise Value
6.26B usd
EV/Revenue
40.2793
EV/EBITDA
381.2407

Key financials

Revenue TTM
118.40M usd
Gross Profit TTM
55.56M usd
EBITDA TTM
11.89M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
389.01M usd
Net debt
N/A usd

About

Sam Chun Dang Pharm. Co., Ltd manufactures, distributes, imports, and exports pharmaceuticals in South Korea. It provides ophthalmology, cardiovascular, endocrinology, antibacterial, anti-fungal, antiviral, respiratory, anti-inflammatory, antihistamine, and musculoskeletal products, as well as vitamins and gastro intestine products. The company was founded in 1943 and is headquartered in Seoul, South Korea.
  • Symbol
    000250.KQ
  • Exchange
    KQ
  • Isin
    KR7000250001
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Pharmaceuticals
  • CEO
    Dae-In Yoon
  • Headquarter
    Seoul
  • Web site
    https://www.scd.co.kr

Related news

Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top